Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Calcium Modification Techniques for Coronary Artery Disease
Author(s): Rodrigo Bagur , Angela McInerney , Rolf Kreutz , et al Start date: Apr 23, 2025
This webinar brings together leading experts Dr Rodrigo Bagur, Dr Angela McInerney, Dr Rolf Kreutz, Dr Sohail Khan, Dr Sophia Khattak, Dr Jonathan Hinton and Dr Peter O’Kane to explore the challenges and solutions in managing calcified coronary artery disease. The session will provide a detailed examination of coronary calcification from pathological and clinical perspectives, including… View more

Intervention
Cracking Coronary Calcium
Author(s): Jie Jun Wong , Yann Shan Keh , Yee How Lau , et al Added: 1 year ago

Intervention
Clinical Features and the Efficacy of Thrombolytic Therapy in de Winter
Author(s): Nirmalatiban Parthiban , Fiona Boland , Huzairi Sani Added: 3 months ago

Prevention & Chronic Conditions

MI/ACS
Author(s): Parinda Kiel , Watthanai Laoakkha , Thananya Boonyasirinant , et al Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 3 months ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
SCAI 25: Insights from the TRITAVI Registry
Author(s): Francesco Pelliccia Added: 2 months ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights… View more

Anticoagulation

Intervention
EHRA 25: The MORE-CRT MPP Trial
Author(s): Christophe Leclercq Added: 3 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire… View more

Electrophysiology & Arrhythmia
ACC 25: The MyPEAK-1 Study
Author(s): Milind Y Desai Added: 3 months ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene… View more

Heart Failure
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Author(s): Harriette Van Spall , Kausik Ray Added: 7 months ago
AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising… View more

Prevention & Chronic Conditions

MI/ACS
Characteristics and Outcomes of Patients Undergoing RotaTripsy
Author(s): Paul Jie Wen Tern , Yann Shan Keh , Yee How Lau , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery